Watzka M - Search Results

1

Comparative genetics of warfarin resistance.

Oldenburg J, Müller CR, Rost S, Watzka M, Bevans CG. Oldenburg J, et al. Among authors: watzka m. Hamostaseologie. 2014;34(2):143-59. doi: 10.5482/HAMO-13-09-0047. Epub 2013 Nov 29. Hamostaseologie. 2014. PMID: 24287886 Review.

2

Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces.

Czogalla KJ, Biswas A, Wendeln AC, Westhofen P, Müller CR, Watzka M, Oldenburg J. Czogalla KJ, et al. Among authors: watzka m. Blood. 2013 Oct 10;122(15):2743-50. doi: 10.1182/blood-2013-05-501692. Epub 2013 Aug 27. Blood. 2013. PMID: 23982176 Free article.

3

Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles.

Oldenburg J, Bevans CG, Fregin A, Geisen C, Müller-Reible C, Watzka M. Oldenburg J, et al. Among authors: watzka m. Thromb Haemost. 2007 Sep;98(3):570-8. Thromb Haemost. 2007. PMID: 17849045 Review.

4

VKORC1: molecular target of coumarins.

Oldenburg J, Watzka M, Rost S, Müller CR. Oldenburg J, et al. Among authors: watzka m. J Thromb Haemost. 2007 Jul;5 Suppl 1:1-6. doi: 10.1111/j.1538-7836.2007.02549.x. J Thromb Haemost. 2007. PMID: 17635701 Free article. Review.

5

[New insight in therapeutic anticoagulation by Coumarin derivatives].

Oldenburg J, Seidel H, Pötzsch B, Watzka M. Oldenburg J, et al. Among authors: watzka m. Hamostaseologie. 2008 Feb;28(1-2):44-50. Hamostaseologie. 2008. PMID: 18278162 Review. German.

6

Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment.

Watzka M, Geisen C, Bevans CG, Sittinger K, Spohn G, Rost S, Seifried E, Müller CR, Oldenburg J. Watzka M, et al. J Thromb Haemost. 2011 Jan;9(1):109-18. doi: 10.1111/j.1538-7836.2010.04095.x. J Thromb Haemost. 2011. PMID: 20946155 Free article.

7

A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay.

Fregin A, Czogalla KJ, Gansler J, Rost S, Taverna M, Watzka M, Bevans CG, Müller CR, Oldenburg J. Fregin A, et al. Among authors: watzka m. J Thromb Haemost. 2013 May;11(5):872-80. doi: 10.1111/jth.12185. J Thromb Haemost. 2013. PMID: 23452238 Free article.

8

VKCFD2 - from clinical phenotype to molecular mechanism.

Czogalla KJ, Watzka M, Oldenburg J. Czogalla KJ, et al. Among authors: watzka m. Hamostaseologie. 2016 Nov 8;36(Suppl. 2):S13-S20. Hamostaseologie. 2016. PMID: 27824210 Review.

9

Determination of the warfarin inhibition constant Ki for vitamin K 2,3-epoxide reductase complex subunit-1 (VKORC1) using an in vitro DTT-driven assay.

Bevans CG, Krettler C, Reinhart C, Tran H, Koßmann K, Watzka M, Oldenburg J. Bevans CG, et al. Among authors: watzka m. Biochim Biophys Acta. 2013 Aug;1830(8):4202-10. doi: 10.1016/j.bbagen.2013.04.018. Epub 2013 Apr 22. Biochim Biophys Acta. 2013. PMID: 23618698 Free article.

10

The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif.

Czogalla KJ, Biswas A, Rost S, Watzka M, Oldenburg J. Czogalla KJ, et al. Among authors: watzka m. Blood. 2014 Aug 21;124(8):1354-62. doi: 10.1182/blood-2013-12-545988. Epub 2014 Jun 24. Blood. 2014. PMID: 24963046 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters